What did @grosspotential actually say?
The creator describes a personal experience: 16 weeks into an anabolic steroid cycle, he developed debilitating cystic acne severe enough that showering was painful, sleeping was disrupted, and he was "getting stuck to my sheets." He then went through five months of Accutane and, over the following years, recovered well enough to compete in bodybuilding. This is a personal testimony, not a medical claim, and that distinction matters for how we evaluate it.
He does not claim to speak for everyone, does not prescribe a protocol, and does not say Accutane is guaranteed to work for steroid-induced acne. That restraint is worth noting. The narrative is grounded in personal consequence, not promotion of drug use.
Does the science back this up?
Yes, robustly. Androgens, including exogenous testosterone and its derivatives, are well-established drivers of acne vulgaris and cystic acne through sebaceous gland stimulation and altered skin microbiome composition.
A 2014 review by Tuchayi et al. in the Journal of the American Academy of Dermatology confirmed that androgen excess directly upregulates sebum production, which feeds the inflammatory cascade behind cystic acne. Studies specifically on anabolic-androgenic steroid (AAS) users, including work by Melnik (2011, Journal of Dermatological Science), show that supraphysiologic androgen exposure drives acne at rates far exceeding natural testosterone levels. The severity the creator describes, including inflammatory nodular cystic lesions, is consistent with AAS-induced acne conglobata, a particularly aggressive presentation documented in case series by Thiboutot et al.
Isotretinoin (Accutane) is the only oral agent with durable efficacy for severe nodulocystic acne, per a 2018 meta-analysis by Huang and Cheng in JAMA Dermatology. Five months of treatment aligns with standard clinical duration for severe cases.
What did they get wrong (or right)?
He got the broad strokes right. The timeline, symptom description, and treatment response are all clinically plausible and consistent with documented AAS-induced acne.
What is missing is context that matters. He does not address that continuing AAS use during or after Accutane treatment significantly undermines outcomes. Isotretinoin works by reducing sebaceous gland activity, but if the androgen signal driving that activity remains, relapse is common. Research by Cunliffe and colleagues has shown that exogenous androgen exposure is one of the strongest predictors of isotretinoin treatment failure or relapse.
He also does not mention that AAS cycles, particularly at bodybuilding doses, carry risks well beyond acne: cardiovascular strain, hepatotoxicity, suppression of the hypothalamic-pituitary-gonadal axis. Framing steroid use primarily through the lens of skin problems, then resolving the skin problems and winning a show, inadvertently makes the trade-off sound manageable. The cardiovascular data says otherwise.
What should you actually know?
If you are using supraphysiologic androgens, whether for bodybuilding or otherwise, cystic acne is a predictable risk, not a rare side effect. The mechanism is not mysterious: more androgens means more sebum means more opportunity for the inflammatory cascade that produces painful, scarring nodules.
Isotretinoin can work, but dermatologists report lower success rates in patients who continue AAS during treatment. The most effective intervention is reducing or eliminating the androgen exposure driving the problem. That is not always what people want to hear, but it is what the evidence supports.
For anyone on a medically supervised testosterone replacement therapy program at physiologic doses, the acne risk is substantially lower than what the creator experienced. His cycle was a bodybuilding context, not TRT, and the distinction in dosing and duration is clinically significant. Do not conflate the two.
- Severe acne on a steroid cycle is a reason to consult a dermatologist, not try to manage it alone.
- Isotretinoin requires medical supervision, regular labs, and in the US, enrollment in the iPLEDGE risk management program.
- Scarring from cystic acne can be permanent. Early treatment intervention reduces long-term skin damage.